Stroke of an undetermined cause was associated with acute symptomatic seizures, an effect that was marginally mediated by cerebral microbleeds.
This article was originally published on Neurology Live. It has been lightly edited.
Findings from a retrospective study of hospitalized patients with anterior circulation ischemic stroke showed an association between cerebral microbleeds (CMBs) and acute symptomatic seizures (ASS). However, this connection was attenuated after accounting for multiple different covariates.
The study is published in Epilepsy & Behavior.
"The presence of CMB alone would be insufficient to explain the onset of seizures after stroke as this is a gradual process, reflecting the prolonged effects of stroke risk factors on cerebral small vessels," lead author Alain Z. Looti, MD, MS, assistant professor, Penn State Neuroscience Institute, and colleagues, wrote. "The presence of cerebral microbleeds may thus indicate a patient with greater risk factors for stroke and thus more likely to have a more severe stroke. Stroke severity, which is associated with an increased risk of seizures, could therefore potentially mediate the relationship between CMB and seizures."
Alain Z. Looti, MD, MS, assistant professor, Penn State Neuroscience Institute
Among a cohort of 381 participants, 17 (4.4%) patients had seizures during hospitalization after the index stroke. On an univariable analysis, the presence of 4 or more CMBs (odds ratio [OR], 3.84; 95% CI, 1.16-12.71) and stroke etiologies were associated with ASS. After adjusting for confounders such as stroke severity, cortical infarct location, and hemorrhagic transformation, the association between CMBs and ASS was reduced (adjusted OR, 3.11; 95% CI, 0.74-11.03; P = .09).
In this single center study, multivariable logistic regression analysis showed that patients with a stroke of undetermined cause were found to be more likely to have ASS (adjusted OR, 5.09; 95% CI, 1.17-35.25; P = .05). A summary of ASS characteristics revealed that time to seizure after stroke was less than 1 day in 71% of the cases, 47% of the ASS were focal, status epilepticus was observed in 6%, and most patients had started on levetiracetam. In causal mediation analysis, findings showed that the effect of CMB on ASS was not mediated by stroke severity.
In terms of the association between cryptogenic strokes and ASS, investigators noted that “establishing causality would be hazardous in the absence of solid biological plausibility and confirmation by other studies.” They continued that confirmatory evidence should come from prospective analyses accounting for the association between cryptogenic strokes, cortical infarcts, and their characteristics.
The study had several limitations, including the fact that seizures were reported by clinicians, with 94% of patients having diagnosis supported by an electroencephalography. In addition, the cohort was limited to patients with anterior circulation stroke, precluding the generalizability of the results to all patients with stroke. Furthermore, there was no information about the localization of CMB relative to seizure onset, as this would have required that all seizures be captured during a continuous electroencephalogram monitoring, which was beyond the scope of the analysis.
Reference
Lekoubou A, Ssentongo P, Maffie J, et al. Associations of small vessel disease and acute symptomatic seizures in ischemic stroke patients. Epilepsy Behav. 2023;145:109233. doi:10.1016/j.yebeh.2023.109233
Infertility Coverage Boosts ART Use and Pregnancy Success: Richard A. Brook, MS, MBA
August 26th 2025In this episode, Richard A. Brook, MS, MBA, discusses his study showing that infertility treatment coverage increases assisted reproductive technology (ART) use and improves pregnancy outcomes.
Listen
The Breakdown: Breast Cancer Research Awareness Day
August 19th 2025Breast cancer is the second most common cancer among women and the second leading cause of cancer-related deaths among women in the US. In light of Breast Cancer Research Awareness Day, The American Journal of Managed Care® breaks down the most recent advancements in breast cancer prevention, screening, and therapies.
Listen
Patients With HFpEF May Benefit From Accelerated Cardiac Pacing
August 28th 2025In an observational extension of the myPACE clinical trial, researchers found that a personalized accelerated pacing in patients with heart failure with preserved ejection fraction (HFpEF) and a preexisting physiological pacer saw a slower trend in adverse cardiac events and overall improved health status.
Read More
Missed Opportunities for Salpingectomy Highlight Gaps in Ovarian Cancer Prevention
August 27th 2025Many patients later diagnosed with high-grade serous cancer had prior surgical or genetic testing opportunities that could have reduced their ovarian cancer risk, underscoring the need to expand opportunistic salpingectomy and preventive strategies.
Read More